BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Koukourakis GV, Zacharias G, Tsalafoutas J, Theodoridis D, Kouloulias V. Capecitabine for locally advanced and metastatic colorectal cancer: A review. World J Gastrointest Oncol 2010; 2(8): 311-321 [PMID: 21160892 DOI: 10.4251/wjgo.v2.i8.311]
URL: https://www.wjgnet.com/1948-5204/full/v2/i8/311.htm
Number Citing Articles
1
Gilad Nahari, Ori Braitbard, Liraz Larush, Jacob Hochman, Edit Y. Tshuva. Effective Oral Administration of an Antitumorigenic Nanoformulated Titanium ComplexChemMedChem 2021; 16(1): 108 doi: 10.1002/cmdc.202000384
2
Leni van Doorn, Niels Heersche, Femke M. de Man, Peter de Bruijn, Ivo Bijl, Esther Oomen‐de Hoop, Ferry A. L. M. Eskens, Ate van der Gaast, Ron H. J. Mathijssen, Sander Bins. Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover TrialClinical Pharmacology & Therapeutics 2022; 111(2): 455 doi: 10.1002/cpt.2444
3
Lukas Schlager, Katharina Wöran, Helena Luhn, Anton Stift, Felix Harpain. A Case Report of Capecitabine-Associated Bowel Inflammation With a Novel Mutation of the DPYD GeneAJSP: Reviews and Reports 2020; 25(4): e8 doi: 10.1097/PCR.0000000000000396
4
Panattharin Lerdkiattikorn, Usa Chaikledkaew, Wirote Lausoontornsiri, Somjin Chindavijak, Thirawud Khuhaprema, Narisa Tantai, Yot Teerawattananon. Cost-utility analysis of adjuvant chemotherapy in patients with stage III colon cancer in ThailandExpert Review of Pharmacoeconomics & Outcomes Research 2015; 15(4): 687 doi: 10.1586/14737167.2015.972379
5
Thulani H. Senanayake, Galya Warren, Xin Wei, Serguei V. Vinogradov. Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugatesJournal of Controlled Release 2013; 167(2): 200 doi: 10.1016/j.jconrel.2013.01.020
6
Sonia Pandey, S. M. Vijayendra Swamy, Arti Gupta, Akshay Koli, Swagat Patel, Furqan Maulvi, Bhavin Vyas. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colonJournal of Microencapsulation 2018; 35(3): 259 doi: 10.1080/02652048.2018.1465138
7
Akhil Santhosh, Akash Kumar, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Ishaan Gupta, Nishkarsh Gupta, Winson Y. Cheung, Ravindra Mohan Pandey, Atul Sharma, Atul Batra. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)Trials 2022; 23(1) doi: 10.1186/s13063-022-06353-2
8
Emilio P. Araujo-Mino, Yehuda Z. Patt, Cristina Murray-Krezan, Joshua A. Hanson, Pranshu Bansal, Ben J. Liem, Ashwani Rajput, M. Houman Fekrazad, Glenory Heywood, Fa Chyi Lee. Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal CancerThe Oncologist 2018; 23(1): 2 doi: 10.1634/theoncologist.2017-0474
9
D. Greto, F. Paiar, C. Saieva, A. Galardi, M. Mangoni, L. Livi, B. Agresti, D. Franceschini, P. Bonomo, V. Scotti, B. Detti, F. Tonelli, A. Valeri, L. Messerini, G. Biti. Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experienceLa radiologia medica 2013; 118(4): 570 doi: 10.1007/s11547-012-0909-4
10
Frederik E. Stuurman, Bastiaan Nuijen, Jos H. Beijnen, Jan H. M. Schellens. Oral Anticancer Drugs: Mechanisms of Low Bioavailability and Strategies for ImprovementClinical Pharmacokinetics 2013; 52(6): 399 doi: 10.1007/s40262-013-0040-2
11
P.H. Rajasree, Willi Paul, Chandra P. Sharma, Riyaz Ali M. Osmani, Umme Hani, Atul Srivastava. Eudragit encapsulated cationic poly (lactic-co-glycolic acid) nanoparticles in targeted delivery of capecitabine for augmented colon carcinoma therapyJournal of Drug Delivery Science and Technology 2018; 46: 302 doi: 10.1016/j.jddst.2018.05.025
12
Bhavesh D. Kevadiya, Shiva Shankaran Chettiar, Shalini Rajkumar, Hari C. Bajaj, Harshad Brahmbhatt, Jayesh C. Chaudhari, Rahul P. Thumbar, Devendrasinh Jhala, Mandava V. Rao. Evaluation of Montmorillonite/Poly (L-Lactide) microcomposite spheres as ambidextrous reservoirs for controlled release of Capecitabine (Xeloda) and assessment of cell cytotoxic and oxidative stress markersComposites Science and Technology 2014; 90: 193 doi: 10.1016/j.compscitech.2013.11.003
13
Fang-Fang Yuan, Rong-Rong Zhang, Xiaoli Ma, Jian Yang, Yan-Ping Huang, Zhao-Sheng Liu. Cooperation effect of 4-vinylbenzeneboronic acid/methacrylic acid on affinity of capecitabine imprinted polymer for drug carrierEuropean Journal of Pharmaceutical Sciences 2020; 154: 105476 doi: 10.1016/j.ejps.2020.105476
14
Iago Dillion Lima Cavalcanti. Chemotherapy Protocols and Infusion Sequence2022; : 125 doi: 10.1007/978-3-031-10839-6_5
15
Kavya Karthikeyan, K V Sameera, Shintu Shaji, M Ann C Swetha, C S Madhu. Capecitabine induced Steven–Johnson syndrome: A rare case reportJournal of Oncology Pharmacy Practice 2022; 28(1): 250 doi: 10.1177/10781552211027945
16
Li‐Ping Zhang, Chun‐E Mo, Yan‐Ping Huang, Zhao‐Sheng Liu. Preparation of Liquid Crystalline Molecularly Imprinted Polymer Coated Metal Organic Framework for Capecitabine DeliveryParticle & Particle Systems Characterization 2019; 36(1) doi: 10.1002/ppsc.201800355
17
Y. Miki, K. Maeda, M. Hosono, H. Nagahara, K. Hirakawa, Y. Shimatani, S. Tsutsumi, Y. Miki. Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I studyJournal of Radiation Research 2014; 55(6): 1171 doi: 10.1093/jrr/rru063